Updates to the Tuberculosis Section of the Adult and Adolescent Opportunistic Infections Guidelines

 

 

 

	OFFERING INFORMATION ON HIV/AIDS TREATMENT, PREVENTION, AND RESEARCH
	At-a-Glance   Issue No. 22 | September 27, 2019 View HTML version     News and Features Updates to the Tuberculosis Section of the Adult and Adolescent Opportunistic Infections Guidelines The Mycobacterium tuberculosis Infection and Disease section of the Guidelines for the Prevention and Treatment of Opportunistic Infections in Adults and Adolescents with HIV has been updated. The Panel updated this section to reflect the availability of results from a number of new studies in tuberculosis (TB) diagnostics, therapeutics, pharmacology, and drug resistance. Several key highlights include: The 3HP regimen (weekly isoniazid plus rifapentine for 3 months) for the treatment of latent tuberculosis infection (LTBI) is now recommended as an alternative regimen when provided as self-administered therapy or directly observed therapy. Four months of daily rifampin monotherapy is now recommended for the treatment of LTBI in patients who cannot receive isoniazid. When dolutegravir is given with concurrent rifampin, it is recommended that the dose be increased to 50 mg twice daily. Bictegravir is not recommended to be given with rifamycin-containing TB treatment. Isoniazid preventive therapy is not recommended for pregnant women until after delivery unless they are close contacts of a known patient with active TB disease. Prednisone is no longer recommended for the treatment of TB pericarditis. Isoniazid-monoresistant TB should be treated with 6 months of rifampin, pyrazinamide, ethambutol, and either levofloxacin or moxifloxacin. For patients at high risk for developing TB-associated immune reconstitution inflammatory syndrome (TB-IRIS), pre-emptive prednisone is recommended as adjunctive therapy with the initiation of antiretroviral therapy.             Home | Guidelines | Understanding HIV/AIDS | Drugs | Clinical Trials | Research Contact Us

 

---

You are subscribed as myhcistech.healthnews360@blogger.com. Update your subscriptions, modify your password or email address, or stop subscriptions at any time on your Subscriber Preferences Page. You will need to use your email address to log in. If you have questions or problems with the subscription service, please visit the GovDelivery Subscriber Help Center at https://insights.govdelivery.com/Communications/Subscriber_Help_Center.

This service is provided to you at no charge by AIDSinfo.

---

This email was sent to myhcistech.healthnews360@blogger.com using GovDelivery Communications Cloud on behalf of: AIDSinfo · P.O. Box 4780· Rockville, MD 20849-6303

NIH awards contracts to advance tuberculosis immunology research

Having trouble viewing this email? View it as a Web page. You are receiving this message because you are subscribed to News Releases for National Institutes of Health (NIH).   NIH awards contracts to advance tuberculosis immunology research 09/26/2019 04:30 PM EDT Research will help advance TB vaccine development. Update Your E-mail Address | Add Subscriptions | Unsubscribe If you have questions or problems with the subscription service, please contact subscriberhelp.govdelivery.com. For all other inquiries about NIH programs and activities, please contact Ask NIH. Before writing, please view our Frequently Asked Questions page, our Health Information page, or Search our website. This service is provided to you by the National Institutes of Health. NIH…Turning Discovery Into Health®      This email was sent to myhcistech.healthnews360@blogger.com using GovDelivery Communications Cloud on behalf of: National Institutes of Health (NIH) · 9000 Rockville Pike · Bethesda MD 20892 · 301-496-4000 / TTY 301-402-9612

Donate today to help us reach our goals

The ADA needs your help to take advantage of the Kahlert Foundation’s offer to match donations up to $100,000

The time to act is now Over 30 million Americans live with diabetes and every year it claims more than 250,000 lives. And research is the key to fighting this reality. The American Diabetes Association® is proud to lead the fight against diabetes—and the Kahlert Foundation is a powerful ally in our work. Their offer to match every gift we receive up to $100,000 to help fund the American Diabetes Association Research Foundation® would mean an awful lot to everyone whose lives are touched by this epidemic. More research means the potential for better ways to prevent, treat, and ultimately cure diabetes. We only have five days left to hit our mark and anything you give today would make a critical difference in this cause. Please, if you’ve never donated before, donate today and help us continue the fight. SUPPORT THE MISSION The Kahlert Foundation has generously committed to providing a guaranteed minimum of $100,000 to this campaign. There’s nothing we can’t do when we’re Connected for Life. VIEW ONLINE  |  UPDATE YOUR PROFILE HERE American Diabetes Association | 2451 Crystal Drive, Suite 900 | Arlington, VA 22202 | 1-800-DIABETES Please add reply@diabetes.org to your address book to ensure you receive all future emails. Click Here to Unsubscribe. © 2019 American Diabetes Association, All rights reserved.

Thursday, September 26, 2019 NIH Awards Contracts to Advance Tuberculosis Immunology Research NIAID has awarded $30 million in first-year funding to establish new centers for tuberculosis immunology research to accelerate progress in TB vaccine development. The contract awards establish three Immune Mechanisms of Protection Against Mycobacterium tuberculosis (IMPAc-TB) Centers to elucidate the immune responses needed to protect against TB-causing bacteria. National Institute of Allergy and Infectious Diseases  |  National Institutes of Health Update your subscriptions, modify your password or e-mail address, or stop subscriptions at any time on your Subscriber Preferences Page. You will need to use your e-mail address to log in. If you have questions or problems with the subscription service, please contact subscriberhelp.govdelivery.com. This service is provided to you at no charge by National Institute of Allergy and Infectious Diseases (NIAID). This email was sent to myhcistech.healthnews360@blogger.com using GovDelivery Communications Cloud on behalf of: National Institute of Allergy and Infectious Diseases · 5601 Fishers Lane · Bethesda, MD 20892 · 1-866-284-4107

Preventing falls | Food allergy | Sleep gene | Dilated eye exam | Fetal alcohol exposure

Learn how to prevent falls, what you can do about a food allergy, why it is important to have a dilated eye exam, and more.

Thursday, September 26, 2019   Preventing Falls Each year millions of Americans, especially older adults, go to the emergency department after an injury from a fall. Learn what you can do to prevent falls. (From NIH News in Health) Food Allergy Food allergies can be very difficult for those living with the allergy and their families. Read more about NIH's commitment to food allergy research. (From NIH's NIAID) Gene Identified In People Who Need Little Sleep Scientists identified a gene that causes people to naturally sleep less than six and a half hours each night without any apparent ill effects. (From NIH Research Matters) Dilated Eye Exam A dilated eye exam is the best thing you can do for your eye health. Discover why. (From NIH's NEI) Fetal Alcohol Exposure Fetal alcohol exposure occurs when a woman drinks while pregnant. Alcohol can disrupt fetal development at any stage during a pregnancy. (From NIH's NIAAA) This bimonthly newsletter contains resources and tips about healthy living and wellness from across NIH, the nation's medical research agency. To find more trusted health information from NIH, go to https://www.nih.gov/health-information. Update Your E-mail Address | Add Subscriptions | Unsubscribe If you have questions or problems with the subscription service, please contact subscriberhelp.govdelivery.com. For all other inquiries about NIH programs and activities, please contact Ask NIH. Before writing, please view our Frequently Asked Questions page, our Health Information page, or Search our website. This service is provided to you by the National Institutes of Health. NIH…Turning Discovery Into Health®      This email was sent to myhcistech.healthnews360@blogger.com using GovDelivery Communications Cloud on behalf of: National Institutes of Health (NIH) · 9000 Rockville Pike · Bethesda MD 20892 · 301-496-4000 / TTY 301-402-9612

Streamlined program integrates expertise from many medical specialties and related basic science disciplines.

Thursday, September 26, 2019 New NIH Program Provides Comprehensive Treatment for Inherited Blood and Immune Diseases Aerial view of the NIH Clinical Center. Credit: National Institutes of Health People with inherited diseases of the blood and immune system can now receive treatment at the NIH Clinical Center through a new, streamlined program that integrates expertise from many medical specialties and related basic science disciplines. Immunologists, transplant specialists, geneticists and hematologists from across NIH are collaborating in the Blood and Immune Deficiency–Cellular Therapy Program. These physicians will deliver state-of-the-art and experimental care to people with rare blood and immune system diseases through a unified approach to assessing, treating and monitoring patients and the centralized tracking of treatment outcomes. National Institute of Allergy and Infectious Diseases  |  National Institutes of Health Update your subscriptions, modify your password or e-mail address, or stop subscriptions at any time on your Subscriber Preferences Page. You will need to use your e-mail address to log in. If you have questions or problems with the subscription service, please contact subscriberhelp.govdelivery.com. This service is provided to you at no charge by National Institute of Allergy and Infectious Diseases (NIAID). This email was sent to myhcistech.healthnews360@blogger.com using GovDelivery Communications Cloud on behalf of: National Institute of Allergy and Infectious Diseases · 5601 Fishers Lane · Bethesda, MD 20892 · 1-866-284-4107

New NIH program provides comprehensive treatment for inherited blood and immune diseases

Having trouble viewing this email? View it as a Web page. You are receiving this message because you are subscribed to News Releases for National Institutes of Health (NIH).   New NIH program provides comprehensive treatment for inherited blood and immune diseases 09/26/2019 11:30 AM EDT Streamlined process integrates expertise from many medical specialties and related basic science disciplines. Update Your E-mail Address | Add Subscriptions | Unsubscribe If you have questions or problems with the subscription service, please contact subscriberhelp.govdelivery.com. For all other inquiries about NIH programs and activities, please contact Ask NIH. Before writing, please view our Frequently Asked Questions page, our Health Information page, or Search our website. This service is provided to you by the National Institutes of Health. NIH…Turning Discovery Into Health®      This email was sent to myhcistech.healthnews360@blogger.com using GovDelivery Communications Cloud on behalf of: National Institutes of Health (NIH) · 9000 Rockville Pike · Bethesda MD 20892 · 301-496-4000 / TTY 301-402-9612